Keyrus Biopharma   Report issue

For profit Phase 1 Phase 2
Founded: Paris France (1998)

Organization Overview

First Clinical Trial
2010
NCT01089608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

azithromycin (zithromax) (1 trial)

hydroxyurea (hydrea) (1 trial)

povidone-iodine (1 trial)

Drugs in Phase 1 Trials (1)

invac-1 (1 trial)

Drugs in Other Trials (2)

everolimus (zortress) (1 trial)

sunitinib (sutent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharitis (Phase 2)

Retinal Vein Occlusion (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 6